Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2011 (2011), Article ID 157510, 4 pages
http://dx.doi.org/10.1155/2011/157510
Case Report

Successful Treatment of Fetal Intraperitoneal Administration of Immunoglobulin in a Case of Fetal Hemolytic Anemia with 131,072-Fold Anti-E Alloimmunization

1Department of Obstetrics and Gynecology, National Defense Medical College, 3-2 Namiki Tokorozawa, Saitama 3598513, Japan
2Division of Obstetrics and Gynecology, Matsuda Perinatal Clinic, 1080-5 Hongo, Tokorozawa, Saitama 3590022, Japan

Received 17 August 2011; Accepted 5 October 2011

Academic Editors: M. H. Eichbaum and Y. Ezra

Copyright © 2011 Masashi Yoshida et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Solola, B. Sibai, and J. M. Mason, “Irregular antibodies: an assessment of routine prenatal screening,” Obstetrics and Gynecology, vol. 61, no. 1, pp. 25–30, 1983. View at Google Scholar · View at Scopus
  2. L. H. Hughes, K. Q. Rossi, D. W. Krugh, and R. W. O'Shaughnessy, “Management of pregnancies complicated by anti-Fy(a) alloimmunization,” Transfusion, vol. 47, no. 10, pp. 1858–1861, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. “ACOG practice bulletin no.75: management of alloimmunization,” Obstetrics and Gynecology, vol. 108, no. 2, pp. 457–464, 2006.
  4. American College of Obstetricians and Gynecologists, “ACOG practice Bulletin No.4: previention of Rh D alloimmunization (May 1999),” International Journal of Gynecology and Obstetrics, vol. 66, pp. 63–70, 1999. View at Google Scholar
  5. The Royal College of Physicians of Edinburgh and The Royal College of Obstetricisans and Gynaecologists, UK, “Statement from the consensus conference on anti-D prophylaxis, 7 and 8 April 1997,” Vox Sanguinis, vol. 74, no. 2, pp. 127–128, 1998. View at Publisher · View at Google Scholar
  6. H. Matsuda, M. Yoshida, H. Wakamatsu, and K. Furuya, “Fetal intraperitoneal injection of immunoglobulin diminishes alloimmune hemolysis,” Journal of Perinatology, vol. 31, no. 4, pp. 289–292, 2011. View at Google Scholar
  7. G. Berlin, A. Selbing, and G. Ryden, “Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin,” The Lancet, vol. 1, no. 8438, p. 1153, 1985. View at Google Scholar · View at Scopus
  8. T. F. Porter, R. M. Silver, G. M. Jackson, D. W. Branch, and J. R. Scott, “Intravenous immune globulin in the management of severe Rh D hemolytic disease,” Obstetrical and Gynecological Survey, vol. 52, no. 3, pp. 193–197, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. J. R. Scott, D. W. Branch, N. K. Kochenour, and K. Ward, “Intravenous immunoglobulin treatment of pregnant patients with recureent pregnancy loss caused by antiphospholipid antibodies and Rh immunization,” American Journal of Obstetrics and Gynecology, vol. 159, no. 5, pp. 1055–1056, 1988. View at Google Scholar
  10. U. Chitkara, J. Bussel, M. Alvarez, L. Lynch, R. L. Meisel, and R. L. Berkowitz, “High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis?” Obstetrics and Gynecology, vol. 76, no. 4, pp. 703–708, 1990. View at Google Scholar · View at Scopus
  11. M. Ballow, “Mechanisms of action of intravenous immune serum globulin therapy,” Pediatric Infectious Disease Journal, vol. 13, no. 9, pp. 806–811, 1994. View at Google Scholar · View at Scopus
  12. “NIH consensus conference. Intravenous immunoglobulin: prevention and treatment of disease,” Journal of the American Medical Association, vol. 264, no. 24, pp. 3189–3193, 1990.
  13. C. J. Wordell, “Use of intravenous immune globulin therapy: an overview,” DICP: The Annals of Pharmacotherapy, vol. 25, no. 7-8, pp. 805–817, 1991. View at Google Scholar · View at Scopus
  14. R. A. Sacher and J. C. King, “Intravenous gammaglobulin in pregnancy: a review,” Obstetrical and Gynecological Survey, vol. 44, pp. 25–34, 1988. View at Google Scholar
  15. C. L. Morgan, G. R. Cannell, R. S. Addison, and R. M. Minchinton, “The effect of intravenous immunoglobulin on placental transfer of a platelet-specific antibody: anti-P1A1,” Transfusion Medicine, vol. 1, no. 4, pp. 209–216, 1991. View at Google Scholar · View at Scopus
  16. K. Aref, F. N. Coctor, S. Pande et al., “Successful perinatal management of hydrops fetalis due to hemolytic disease associated with D—maternal phenotype,” Journal of Perinatology, vol. 22, no. 8, pp. 667–668, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Yoshida, H. Matsuda, K. Furuya et al., “Accumulation of fetal IgG in immunoglobulin injection into fetal abdominal cavity is proven,” Fetal Diagnosis and Therapy, vol. 29, pp. 229–232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Kawakami, H. Matsuda, T. Shibasaki, M. Yoshida, and K. Furuya, “Safer cordocentesis by new 25-gauge needles,” Fetal Diagnosis and Therapy, vol. 24, no. 3, pp. 211–217, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J. C. Burns, E. V. Capparelli, J. A. Brown, J. W. Newburger, and M. P. Glode, “Intravenous gamma-globulin treatment and retreatment in Kawasaki disease,” Pediatric Infectious Disease Journal, vol. 17, no. 12, pp. 1144–1148, 1998. View at Publisher · View at Google Scholar · View at Scopus